| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief R&D Officer | SVP Clinical Development, CMO | VP Clinical Development, CMO
2 companies
Thackray Helen M. is a Chief R&D Officer at BCRX with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $7.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2016 | CBIO Crescent Biopharma, Inc. | VP Clinical Development, CMO | Sell | 22,000 | $7.00 | $153,953.84 | -4.1% |